	Label	Description
	prostate carcinoma Disease (Entity type)	A prostate cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial ...
	Homo sapiens Taxonomy (Entity type)	man
	L1000 LINCS DCIC LJP006 LNCAP 3H A14 alvocidib 3.33um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC LJP006 LNCAP 3H E01 PD-0325901 10.00um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC 2021 LJP006 LNCAP 24H F20 QL-X-138 3.33uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 LJP006 LNCAP 3H F22 QL-X-138 0.37uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 DTAK003 LNCAP 24H O12 enzastaurin 2.5uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 LJP006 LNCAP 3H O08 AS-605240 3.33uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 LJP006 LNCAP 24H C16 fostamatinib 0.37uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC LJP006 LNCAP 24H L12 WYE-125132 0.04um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project

prostate carcinoma

A prostate cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial ...

Homo sapiens

man

L1000 LINCS DCIC LJP006 LNCAP 3H A14 alvocidib 3.33um

A biosample from LINCS produced as part of the L1000 Phase2 project

L1000 LINCS DCIC LJP006 LNCAP 3H E01 PD-0325901 10.00um

A biosample from LINCS produced as part of the L1000 Phase2 project

L1000 LINCS DCIC 2021 LJP006 LNCAP 24H F20 QL-X-138 3.33uM